Validation of the visual acuity iPad app Eye Chart Pro compared to the standard Early Treatment Diabetic Retinopathy Study chart in a low-vision population.

Introduction: A low-vision assessment (LVA) is central to developing a vision rehabilitation plan. However, access to LVAs is often limited by the quantity and geographic distribution of low-vision providers, as well as patient-centred transportation challenges. A tablet-based LVA tool kit, delivered virtually, has the potential to overcome many of these barriers. The purpose of this research was to validate a key component of the tablet-based tool kit - a commercially available iPad visual acuity (VA) test (Eye Chart Pro) iPad app - in a low-vision population.

Methods: Participants with low vision ( = 26) and those who were normally sighted ( = 25) underwent VA testing with both the iPad VA test application and the Early Treatment Diabetic Retinopathy Study (ETDRS) chart. The VA data were compared using a -test, linear regression and Bland-Altman analysis.

Results: There was no significant difference in the mean absolute difference in VA (log of minimum angle of resolution (logMAR)=0.11;  = 0.82). Eye Chart Pro and Standard ETDRS Chart measures were also not significantly different ( = 0.98). However, there were significant differences between test methods in the low-vision group and the normally sighted group ( > 0.0001 and  = 0.007, respectively). The Bland-Altman analysis showed a mean bias (difference) of -0.0005 logMAR between methods, and 95% limits of agreement of 0.298 and -0.299 logMAR.

Discussion: The ETDRS chart function on the Eye Chart Pro application can reliably measure VA across a range, from normally sighted patients to those with low vision.